Literature DB >> 26077564

Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?

Jan Wysocki1, Lisa Wilsbacher1, Daniel Batlle2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26077564      PMCID： PMC4624410          DOI： 10.1161/HYPERTENSIONAHA.115.05093

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  12 in total

1.  Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.

Authors:  Robson A S Santos; Anderson J Ferreira; Ana Paula Nadu; Aline N G Braga; Alvair Pinto de Almeida; Maria José Campagnole-Santos; Ovidiu Baltatu; Radu Iliescu; Timothy L Reudelhuber; Michael Bader
Journal:  Physiol Genomics       Date:  2004-05-19       Impact factor: 3.107

Review 2.  Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives.

Authors:  Federico Cacciapuoti
Journal:  J Am Soc Hypertens       Date:  2011-10-20

3.  Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

Authors:  Justin L Grobe; Adam P Mecca; Haoyu Mao; Michael J Katovich
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-13       Impact factor: 4.733

Review 4.  MAS and its related G protein-coupled receptors, Mrgprs.

Authors:  Michael Bader; Natalia Alenina; Miguel A Andrade-Navarro; Robson A Santos
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

5.  Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling.

Authors:  Nívia M Santiago; Priscila S Guimarães; Raquel A Sirvente; Laser A M Oliveira; Maria C Irigoyen; Robson A S Santos; Maria J Campagnole-Santos
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

6.  Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.

Authors:  Pedro W Machado de Almeida; Marcos Barrouin Melo; Ricardo de Freitas Lima; Mariana Gavioli; Nivia M Santiago; Leonardo Greco; Itamar C G Jesus; Eduardo Nocchi; Amanda Parreira; Marcia N M Alves; Luciana Mitraud; Rodrigo Ribeiro Resende; Maria José Campagnole-Santos; Robson Augusto Souza Dos Santos; Silvia Guatimosim
Journal:  Hypertension       Date:  2015-06-15       Impact factor: 10.190

7.  Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).

Authors:  Justin L Grobe; Adam P Mecca; Melissa Lingis; Vinayak Shenoy; Tonya A Bolton; Juline M Machado; Robert C Speth; Mohan K Raizada; Michael J Katovich
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-10       Impact factor: 4.733

8.  Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Norihito Moniwa; K Bridget Brosnihan; Jan Wysocki; Daniel Batlle; Carlos M Ferrario
Journal:  Am J Hypertens       Date:  2013-03-04       Impact factor: 2.689

9.  Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Authors:  Jan Wysocki; Minghao Ye; Eva Rodriguez; Francisco R González-Pacheco; Clara Barrios; Karla Evora; Manfred Schuster; Hans Loibner; K Bridget Brosnihan; Carlos M Ferrario; Josef M Penninger; Daniel Batlle
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

10.  ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts.

Authors:  Justin L Grobe; Shant Der Sarkissian; Jillian M Stewart; J Gary Meszaros; Mohan K Raizada; Michael J Katovich
Journal:  Clin Sci (Lond)       Date:  2007-10       Impact factor: 6.124
View more
  2 in total

1.  Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Authors:  Christoph Maier; Ines Schadock; Philipp K Haber; Jan Wysocki; Minghao Ye; Yashpal Kanwar; Christopher A Flask; Xin Yu; Brian D Hoit; Gregory N Adams; Alvin H Schmaier; Michael Bader; Daniel Batlle
Journal:  J Mol Med (Berl)       Date:  2017-02-03       Impact factor: 4.599

2.  A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13.

Authors:  Pan Liu; Jan Wysocki; Peter Serfozo; Minghao Ye; Tomokazu Souma; Daniel Batlle; Jing Jin
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.